InVitro International (OTCPK:IVRO) - Stock Price, News & Analysis

IVRO Stock Overview

Develops test kits for non-animal testing applications in the United States and internationally. More details

IVRO fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($2M)

High level of non-cash earnings

Makes less than USD$1m in revenue ($793K)

Revenue has declined by 7.1% over the past year

+ 3 more risks

InVitro International Competitors

Procyon

OTCPK:PCYN

US$1.6m

Vycor Medical

OTCPK:VYCO

US$3.3m

Arch Therapeutics

OTCPK:ARTH

US$1.0m

Meihua International Medical Technologies

NasdaqGM:MHUA

US$16.9m

Price History & Performance

Summary of all time highs, changes and price drops for InVitro International
Historical stock prices
Current Share Price	US$0.08
52 Week High	US$0.12
52 Week Low	US$0.025
Beta	-0.88
11 Month Change	-20.00%
3 Month Change	n/a
1 Year Change	33.33%
33 Year Change	-48.39%
5 Year Change	0%
Change since IPO	-97.22%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IVRO	US Medical Equipment	US Market
7D	-27.3%	-0.4%	-1.0%
1Y	33.3%	20.3%	30.3%

Return vs Industry: IVRO exceeded the US Medical Equipment industry which returned 20.3% over the past year.

Return vs Market: IVRO exceeded the US Market which returned 30.3% over the past year.

Price Volatility

Is IVRO's price volatile compared to industry and market?
IVRO volatility
IVRO Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: IVRO's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IVRO's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1985	n/a	Rich Ulmer	www.invitrointl.com

InVitro International develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services.

InVitro International Fundamentals Summary

How do InVitro International's earnings and revenue compare to its market cap?
IVRO fundamental statistics
Market cap	US$1.81m
Earnings (TTM)	US$1.55k
Revenue (TTM)	US$792.63k

1,167x

P/E Ratio

2.3x

P/S Ratio

Is IVRO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IVRO income statement (TTM)
Revenue	US$792.63k
Cost of Revenue	US$156.64k
Gross Profit	US$635.99k
Other Expenses	US$634.43k
Earnings	US$1.55k

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	0.000069
Gross Margin	80.24%
Net Profit Margin	0.20%
Debt/Equity Ratio	0%

How did IVRO perform over the long term?

See historical performance and comparison